A commercial anti-cancer drug, axitinib, exhibits very stable dual emissions for discrimination of human serum albumin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d4cc01944j | DOI Listing |
Publication Analysis
Top Keywords
anti-cancer drug
8
drug axitinib
8
axitinib unique
4
unique tautomerism-induced
4
tautomerism-induced dual-emissive
4
dual-emissive probe
4
probe protein
4
protein analysis
4
analysis commercial
4
commercial anti-cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!